ROS1 and inflammatory breast carcinoma: Although the hormonal status of these patients were not described in the paper, a prior case report on inflammatory breast cancer harboring CD74-ROS1 was triple negative [17] and so were 3 out of 7 cases of ROS1+ breast cancer in our study.